IL6 and neoplasm: PMCs prevent initial tumor cell invasion by secreting TNFα, CRC cells secrete IL‐6, and IL‐10 converts these anti‐tumorigenic PMCs to a pro‐tumorigenic M2 phenotype favoring tumor progression [226].